Polaris is a North Carolina-based biotechnology company that provides quantum drug discovery solutions for the healthcare industry... Read more
Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
1-25
Agree?
Funding
$2.6M

News

Feb 28, 2025
Polaris Quantum Biotech Inc Blog
Polaris Quantum Biotech Inc Blog An Investigation of Allostery in Epidermal Growth Factor Receptor Using Sextant with Dynamics Simulations to Expand an Apo Site
Jan 19, 2025
Polaris Quantum Biotech Inc Blog
Polaris Quantum Biotech Inc Blog Combinatorial Optimization vs. Physical Simulation
Jan 12, 2025
Polaris Quantum Biotech Inc Blog
Polaris Quantum Biotech Inc Blog Quantum-Aided Drug Design for Inhibiting Protein-Protein Interactions for Emerging Threats
Nov 24, 2024
Polaris Quantum Biotech Inc Blog
Polaris Quantum Biotech Inc Blog Hybrid Quantum Approach for Sampling Molecular Fragment Libraries to Discover Novel Therapeutics for Ebola
Nov 22, 2024
Polaris Quantum Biotech Inc Blog
Polaris Quantum Biotech Inc Blog Fail Fast, Find Faster
Nov 10, 2024
Polaris Quantum Biotech Inc Blog
Polaris Quantum Biotech Inc Blog Sextant: A New Tool for Designing Custom Molecular Templates for Protein-Protein Interaction Inhibitor Drug Design
Oct 18, 2024
Polaris Quantum Biotech Inc Blog
Polaris Quantum Biotech Inc Blog Webinar: Using QuaDD to Accelerate Discovery for Versatile Targets
Sep 20, 2024
Polaris Quantum Biotech Inc Blog
Polaris Quantum Biotech Inc Blog PolarisQB Joins OpenFold AI Consortium along with Congruence, Biogen, Psivant and Others
Aug 19, 2024
Polaris Quantum Biotech Inc Blog
Polaris Quantum Biotech Inc Blog Integration of Virtual Libraries from Liverpool ChiroChem into Quantum-Aided Drug Design
Aug 13, 2024
Benzinga
Polaris Quantum Biotech Inc: OpenFold AI Research Consortium Welcomes Six New Members: Astex, Biogen, Congruence, Polaris Quantum, Psivant, and SandboxAQ

Trending Companies